June 13, 2016

HURRY – Only 8 Days Left to Register!
We hope you can join us for the NRG Oncology Semiannual Meeting, July 14-16, 2016 at the Sheraton Dallas Hotel in Dallas, TX. Registration deadline is Tuesday, June 21, 2016! Please pre-register online for this meeting by June 21, 2016. Registering onsite at the meeting will incur an additional $50 fee. Registration and meeting information is available on the NRG Oncology website.

Marvella Ford, PhD to speak at special NRG Oncology Workshop on Cultural Competency in Clinical Trials
This workshop, on Friday, July 15, at 11 a.m., is designed for NRG Oncology research investigators, nurses, CRAs, and support staff to understand the role cultural competency plays in clinical trials. With recruitment of patients from underrepresented minority groups in clinical trials at less than 1%, there is an opportunity to reduce this gap in health disparity! Don't forget to register.

GOG-0264: Amendment 4; version date: December 19, 2014

GOG-9927: Amendments 9 and 10 have replaced the Amendment 9 document previously posted with the May 23, 2016 broadcast

RTOG 1306: Study Memorandum dated June 6, 2016; Study Memorandum dated June 8, 2016. The memoranda are also available on the CTSU website. Formatting and typographical errors to the Summary of Changes were corrected. No changes were made to the content of the Summary of Changes.

NSABP B-38: Upcoming Study Closure Notice (posted to NSABP and CTSU)

NSABP B-51/RTOG 1304: E-mail Blast (Posted to NSABP and CTSU websites)

NSABP-B-55/BIG-6-13: OlympiA Newsletter, 6th Issue (posted to CTSU)

NRG-GY004 and NRG-GY005: Mandatory Toxicity Management Training SIVs – Revised Dates

NRG-GY004 and NRG-GY005: BROCA-HR whole blood (WB01) and unstained slides (FP02 or FM02) shipped to the Swisher Lab at the University of Washington

Vision Tree Webinar
The next VTOC training session will be face to face at the NRG Semiannual Meeting July 14, 2016 at 1pm CDT. The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for August 10, 2016.

Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

IB updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page.

Safety updates have been issued for the following NRG Oncology studies:
Ipilimumab: NRG-G003, NRG-BN002
Nivolumab: NRG-GY002, NRG-GY003, NRG-BN002
-For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on the NRG Oncology website for details.
-For NRG-BN002 safety reports, please see the RTOG General Broadcast page for details.

ASCO Interview with Dr. Curran now featured on MedPage Today
Walter J. Curran Jr., MD, an NRG Oncology Group Chair, was recently interviewed regarding adjuvant temozolomide in elderly patients with glioblastoma at the 2016 American Society of Clinical Oncology Annual Meeting. The full interview video is available on MedPage Today’s website.

Drs. Wolmark and Geyer to speak at inaugural breast cancer meeting in China
Norman Wolmark, MD, an NRG Oncology Group Chair, and Charles E. Geyer, Jr., MD, Associate Director for Clinical Research at Virginia Commonwealth University Massey Cancer Center, are invited speakers at the inaugural Guangzhou Breast Cancer Symposium being held in Guangzhou, China on June 17-18. The symposium, which will be attended by more than 500 expert medical oncologists and surgeons from China and will feature speakers from the United States and Great Britain, is being organized by Ning Liao, MD, a leading breast cancer researcher and head of the Breast Department, Cancer Center at Guangdong General Hospital in Guangzhou, China.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Bar-Ad V, Zhang QE, Harari PM, Axelrod R, Rosenthal DI, Trotti A, Jones CU, Garden AS, Song G, Foote RL, Raben D, Shenouda G, Spencer SA, Harris J, Le QT. Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience. Int J Radiat Oncol Biol Phys. 2016 Mar 26. pii: S0360-3016(16)00323-0. doi: 10.1016/j.ijrobp.2016.03.011. [Epub ahead of print] PubMed PMID: 27212198. Read more

Eaton BR, Pugh SL, Bradley JD, Masters G, Kavadi VS, Narayan S, Nedzi L, Robinson C, Wynn RB, Koprowski C, Johnson DW, Meng J, Curran WJ Jr. Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. J Natl Cancer Inst. 2016 May 19;108(9). pii: djw034. doi: 10.1093/jnci/djw034. Print 2016 Sep. PubMed PMID: 27206636. Read more

Ohri N, Duan F, Snyder BS, Wei B, Machtay M, Alavi A, Siegel BA, Johnson DW, Bradley JD, DeNittis A, Werner-Wasik M, El Naqa I. Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235. J Nucl Med. 2016 Jun;57(6):842-8. doi: 10.2967/jnumed.115.166934. Epub 2016 Feb 11. PubMed PMID: 26912429. Read more

Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y. How Will Big Data Improve Clinical and Basic Research in Radiation Therapy? Int J Radiat Oncol Biol Phys. 2015 Nov 11. pii: S0360-3016(15)26703-X. doi: 10.1016/j.ijrobp.2015.11.009. [Epub ahead of print] PubMed PMID: 26797542; PubMed Central PMCID: PMC4864183. Read more

Wells JS, Pugh S, Boparai K, Rearden J, Yeager KA, Bruner DW. Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials-an NRG Oncology RTOG Study. J Cancer Educ. 2016 May 21. [Epub ahead of print] PubMed PMID: 27209044. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
Multinational Association of Supportive Care in Cancer (MASCC), Jun 23-25, 2016, Adelaide, Australia

American Brachytherapy Society (ABS), Jun 27-29, 2016, San Francisco, CA

American Head & Neck Society (AHNS), Jul 16-20, 2016; Seattle, WA

Upcoming abstract submission deadlines
European Society for Medical Oncology (ESMO), Oct 7-11, 2016, Copenhagen, Denmark; meeting abstract submission deadline Aug 23, 2016 LBA

Society for Neuro-Oncology (SNO), Nov 17-20, 2016, Scottsdale, AZ; meeting abstracts submission deadline Jun 13, 2016 New abstract submission requirements

San Antonio Breast Cancer Symposium (SABCS), Dec 6-20, 2016, San Antonio, TX; meeting abstracts submission deadline Jun 13, 2016

Society of Clinical Research (SOCRA), Sep 30-Oct 2, 2016; Montreal, QC, Canada; due to publications committee Jul 15, 2016; meeting abstracts submission deadline Jul 29, 2016

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103